Diamyd Medical

1,05 SEK

+3,33%

Mindre end 1K følgere

DMYD B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Diamyd Medical

P/E

Medianen 2019-2025

EV/S

Medianen 2019-2022

EV/EBIT

Medianen 2019-2022

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)8,1138,4432,7514,179,7416,3411,30
Aktier71,271,273,679,277,3100,2137,5
Markedsværdi577,62.735,62.411,91.121,6753,11.637,51.553,7
Enterprise value521,62.668,02.273,31.002,6---
EV/S332,77.824,28.985,32.228,0---
EV/EBITDAneg.269,8neg.neg.---
EV/EBITneg.274,0neg.neg.---
P/Eneg.281,940,2neg.neg.neg.neg.
P/B9,2037,7412,745,234,0711,225,55
P/S368,38.022,49.533,12.492,41.369,312.595,811.951,9
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %
Equity ratio84,6 %80,8 %94,0 %90,6 %90,0 %67,2 %79,4 %
Gearing ratio1,2 %1,1 %0,4 %0,4 %0,4 %--